A New Tool to Promote Patient's Engagement in Their Healthcare Process
Recruiting · NCT06762496 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Healthcare professionalsPatients PDA groupPatients control group
What this trial is about
Women diagnosed with early-stage breast cancer need to make a decision about the therapeutic treatment to undertake. Since multiple factors can influence this decision, it is necessary to develop a decision-making support tool to assist them in making this choice. Main Objective: To develop a decision-making support tool for determining the treatment to undertake for women diagnosed with early-stage breast cancer and test its effectiveness on an experimental group.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- be 18 or older;
- have received/receive diagnosis of resectable breast cancer in the early stage;
- women treated or who will undergo oncological treatment for early breast cancer;
- demonstrate the absence of psychopathological features.
- be willing and able to provide written informed consent/assent for the trial
Exclusion criteria
- breast cancer patients who showed physical or psychological issues, as well as cognitive impairments that prohibited their participation in this type of study;
- neurological or psychiatric disorders that may compromise the patients' ability to take part in the study.
- Distant metastases from breast cancer or locally advanced/unresectable disease
- Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Where it is running
1 location listed.
- European Institute of Oncology - Milan, Italy, Italy